Chat with us, powered by LiveChat
  • About
  • Terms of Use
  • Privacy & Policy
  • Cookie policy
  • “[email protected]”.
USTechTimes, Magazine & Review WordPress Theme 2017
  • Home
  • topics
    • All
    • AgTech
    • AI
    • Analytics
    • AR/VR
    • Biotech
    • Blockchain
    • Cars / autonomous vehicles
    • Clean tech / environment
    • Cloud infrastructure
    • Cryptocurrency
    • Data services
    • Developer tools
    • E-commerce
    • Education
    • Energy tech
    • Enterprise
    • Entertainment & sports
    • Security
    Sunstone Credit secures $20 million in Series A funding round

    Sunstone Credit secures $20 million in Series A funding round

    New-York based Impel secures $104 million in growth funding

    New-York based Impel secures $104 million in growth funding

    Metagenomi bags an extra $100 million before closing its Series B

    Metagenomi bags an extra $100 million before closing its Series B

    Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

    Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

    Trending Tags

      • Advertising
      • AgTech
      • AI
      • Analytics
      • AR/VR
      • Biotech
      • Blockchain
      • Cars / autonomous vehicles
      • Clean tech / environment
      • Cloud infrastructure
      • Consumer health & fitness
      • Consumer products
      • Cryptocurrency
      • Data services
      • Developer tools
      • Distributed workforce
      • E-commerce
      • Education
      • Energy tech
      • Enterprise
      • Entertainment & sports
      • Fashion
      • Fintech
      • Food and beverage
      • Games
      • Gaming/eSports
      • Govtech
      • Hardware
      • Health & hospital services
      • Health IT
      • Human capital
      • Impact
      • Insurance
      • IoT
      • Local commerce
      • Lodging/hospitality
      • Logistics
      • Manufacturing
      • Marketing automation
      • Marketplaces
      • Material science
      • Media/content
      • Medical devices
      • Messaging
      • Network infrastructure
      • Parenting/families
      • Payments
      • Pharmaceuticals
      • Real estate/proptech
      • Retail
      • Robotics
      • SaaS
      • Sales and CRM
      • Security
      • SMB software
      • Social commerce
      • Social mobile
      • Space
      • Gaming/eSports
      • Travel
      • Games
    • Interview
    • Venture Capital
    No Result
    View All Result
    • Home
    • topics
      • All
      • AgTech
      • AI
      • Analytics
      • AR/VR
      • Biotech
      • Blockchain
      • Cars / autonomous vehicles
      • Clean tech / environment
      • Cloud infrastructure
      • Cryptocurrency
      • Data services
      • Developer tools
      • E-commerce
      • Education
      • Energy tech
      • Enterprise
      • Entertainment & sports
      • Security
      Sunstone Credit secures $20 million in Series A funding round

      Sunstone Credit secures $20 million in Series A funding round

      New-York based Impel secures $104 million in growth funding

      New-York based Impel secures $104 million in growth funding

      Metagenomi bags an extra $100 million before closing its Series B

      Metagenomi bags an extra $100 million before closing its Series B

      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

      Trending Tags

        • Advertising
        • AgTech
        • AI
        • Analytics
        • AR/VR
        • Biotech
        • Blockchain
        • Cars / autonomous vehicles
        • Clean tech / environment
        • Cloud infrastructure
        • Consumer health & fitness
        • Consumer products
        • Cryptocurrency
        • Data services
        • Developer tools
        • Distributed workforce
        • E-commerce
        • Education
        • Energy tech
        • Enterprise
        • Entertainment & sports
        • Fashion
        • Fintech
        • Food and beverage
        • Games
        • Gaming/eSports
        • Govtech
        • Hardware
        • Health & hospital services
        • Health IT
        • Human capital
        • Impact
        • Insurance
        • IoT
        • Local commerce
        • Lodging/hospitality
        • Logistics
        • Manufacturing
        • Marketing automation
        • Marketplaces
        • Material science
        • Media/content
        • Medical devices
        • Messaging
        • Network infrastructure
        • Parenting/families
        • Payments
        • Pharmaceuticals
        • Real estate/proptech
        • Retail
        • Robotics
        • SaaS
        • Sales and CRM
        • Security
        • SMB software
        • Social commerce
        • Social mobile
        • Space
        • Gaming/eSports
        • Travel
        • Games
      • Interview
      • Venture Capital
      No Result
      View All Result
      USTechTimes - Leading Startup and Technology News in the United States
      No Result
      View All Result
      Home topics Biotech

      Metagenomi bags an extra $100 million before closing its Series B

       97 total views,  1 views today

      Metagenomi aims to create potentially curative treatments by using a collection of next-generation gene editing tools to edit DNA.

      USTechTimes Editor by USTechTimes Editor
      January 11, 2023
      Metagenomi bags an extra $100 million before closing its Series B
      Share on FacebookShare on Twitter

      Metagenomi, an Emeryville, California-based Genetic medicines company, raised $100 million, concluding a Series B extension financing. The funding round was co-led by Novo Holdings, Catalio Capital Managements and SymBiosis, with contributions from new and existing investors.

      “This additional capital gives us visibility on initial clinical milestones as well as an expanded pipeline of in vivo gene editing applications,” said Brian C. Thomas, CEO and Founder of Metagenomi.

      With over 30 investor organizations participating, the most recent financing rounds have increased Series B’s total proceeds to $275 million. The manufacturer of the next-generation gene editing tools constructed a cutting-edge Good Manufacturing Practices (GMP) facility in October of last year to assist its development.

      As we begin a new year, we wanted to take a moment and reflect on what we accomplished in 2022. Here are just a few highlights! We can't wait to continue our work on novel gene editing technologies in 2023 and get one step closer to treating patients in need. pic.twitter.com/z46OZ1jcVm

      — Metagenomi (@metagenomi) January 3, 2023

      “The closing of this Series B extension financing is a testament to our significant progress over the past year. We further expanded our toolbox of wholly-owned, next-generation gene editing technologies, embarked on our first nonhuman primate (NHP) in vivo gene editing proof-of-concept studies and strengthened our strategic business development alliances,” said Brian C. Thomas

      The flexible and modular facility would support the company’s ambition to create precise gene-editing tools and treat diseases with high unmet demand. The development of its early clinical proprietary and collaborative therapy programs will be made possible by this first stage.

      Metagenomi’s goal is to revolutionize gene editing for the benefit of patients around the world

      The goal of Metagenomi, a business specializing in gene editing, is to create potentially curative treatments by using a collection of next-generation gene editing tools to edit DNA in situations where existing technologies fall short precisely.

      The biotech company’s analytical know-how and discovery platform identify novel cellular machinery derived from previously unidentified organisms. These naturally evolved mechanisms are modified and transformed into potent gene editing tools that are incredibly tiny, highly efficient, highly specific, and less likely to elicit an immune response. These systems fuel their pipeline of innovative medications.

      “Metagenomi’s next-generation technology platform, preclinical progress, numerous validating partnerships and strong investors, we believe the Company is well positioned to rapidly develop therapeutics to treat a broad range of genetic diseases,” said Ray Camahort, Ph.D., Partner at Novo Ventures.

      After forming profitable alliances with Moderna and Ionis Pharmaceuticals, Metagenomi has a sizable cash runway. With this extra funding, the company can push its lead therapeutic projects through preclinical development and into clinical proof-of-concept.

      The company also intends to add more therapeutic targets to its pipeline of genetic medicines, which will be expanded into more preclinical proof-of-concept trials thanks to its automated discovery engine and flexible gene editing toolset.

      What’s your thoughts?
      +1
      0
      Upvote
      +1
      0
      Clap
      +1
      0
      Clap
      +1
      0
      On fire
      +1
      0
      Meh
      +1
      0
      Clap
      +1
      0
      Facebook Twitter Email

      Related Posts

      • New York-based AI firm Dataiku secures $200 million in its Series F

        New York-based AI firm Dataiku secures $200 million in its Series F New York-based artificial…

      • MasterControl secures their first-ever funding of $150 million in its Series A

        MasterControl, a Utah-based quality and manufacturing software solutions provider, has secured its first-ever funding of…

      • Group 14 technologies bags additional $214 million in its Series C funding

        A consortium has invested $214 million in Group14 Technologies, a battery manufacturer in Woodinville, Washington.…

      Tags: BiotechfundingMedical tech startup
      USTechTimes Editor

      USTechTimes Editor

      USTechTimes.com is an independent new media site that focuses on the latest technology and digital news in the United States and around the world. The site focuses on new startup launching, startup funding, and development in the startup space.

      Related Posts

      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank
      Biotech

      Aspen Neuroscience sign $40 million debt deal with Silicon Valley Bank

      December 30, 2022
      Bezos Bets on Silicon Valley’s Latest Wild Flutter of Staying Young Forever
      Biotech

      Bezos Bets on Silicon Valley’s Latest Wild Flutter of Staying Young Forever

      September 7, 2021
      Vaccitech Announces Initial Public Offering
      Biotech

      Vaccitech PLC, the company behind AstraZeneca Covid-19 vaccine files for US IPO

      May 4, 2021
      Tapestri Platform
      Biotech

      Mission Bio Raises $70M in Series C Funding Led by Novo Holdings

      August 15, 2020
      No Result
      View All Result

      Follow Us

      FREE NEWSLETTER

       

      PRODUCTS

      USTechTimes – Leading Startup and Technology News in the United States

      USTechTimes.com is an independent new media site that focuses on the latest technology and digital news in the United States and around the world. The site focuses on new startup launching, startup funding, and development in the startup space.

      More from our network


      • ktd

      • atd

      • itd

      • ktt

      • kgd

      • kpp

      • ktp

      • kpoppost

      • ustechtimes

      Categories

      • Accelerator
      • Animation
      • Apple
      • Applications
      • Artificial Intelligence
      • Advertising
      • AgTech
      • AI
      • Analytics
      • AR/VR

      Tags

      Fintech Health Technology funding Robotics US startup AI investment Healthtech Artificial Intelligence Software
      • About
      • Terms of Use
      • Privacy & Policy
      • Cookie policy
      • “press@ustechtimes.com”.

      © 2023 ustechtimes.com

      No Result
      View All Result
      • Home
      • topics
        • Advertising
        • AgTech
        • AI
        • Analytics
        • AR/VR
        • Biotech
        • Blockchain
        • Cars / autonomous vehicles
        • Clean tech / environment
        • Cloud infrastructure
        • Consumer health & fitness
        • Consumer products
        • Cryptocurrency
        • Data services
        • Developer tools
        • Distributed workforce
        • E-commerce
        • Education
        • Energy tech
        • Enterprise
        • Entertainment & sports
        • Fashion
        • Fintech
        • Food and beverage
        • Games
        • Gaming/eSports
        • Govtech
        • Hardware
        • Health & hospital services
        • Health IT
        • Human capital
        • Impact
        • Insurance
        • IoT
        • Local commerce
        • Lodging/hospitality
        • Logistics
        • Manufacturing
        • Marketing automation
        • Marketplaces
        • Material science
        • Media/content
        • Medical devices
        • Messaging
        • Network infrastructure
        • Parenting/families
        • Payments
        • Pharmaceuticals
        • Real estate/proptech
        • Retail
        • Robotics
        • SaaS
        • Sales and CRM
        • Security
        • SMB software
        • Social commerce
        • Social mobile
        • Space
        • Gaming/eSports
        • Travel
        • Games
      • Interview
      • Venture Capital

      © 2023 ustechtimes.com